Glass Vaccine Vial Market to Reach US$1.54 Billion by 2031 | Molded Glass Vial Segment Dominates with Superior Stability and Safety Properties | DataM Intelligence

Leander, Texas and Tokyo, Japan - Nov 28, 2025
According to DataM Intelligence, the global glass vaccine vial market was valued at US$0.75 billion in 2024 and is forecasted to reach US$1.54 billion by 2031, growing at a CAGR of 10.78% during the forecast period (2024-2031). This robust growth is propelled by increasing global vaccination programs, rising infectious disease prevalence, growing biopharmaceutical production, expanding immunization initiatives, and stringent regulatory requirements for vaccine packaging safety and stability.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/glass-vaccine-vial-market?jd

Report Details:
• No. of Pages: 190
• Forecast Period: 2024-2031
• Estimated Market Value (USD) in 2024: $0.75 Billion
• Forecasted Market Value (USD) by 2031: $1.54 Billion
• Compound Annual Growth Rate: 10.78%
• Regions Covered: Global

United States Recent Developments:
✅ Corning Incorporated launched Valor® Glass vials with enhanced chemical durability and reduced breakage for mRNA vaccine storage
✅ SCHOTT Pharma expanded molded glass vial production capacity to meet growing COVID-19 booster and seasonal flu vaccine demand
✅ US FDA approved new Type I borosilicate glass formulations with improved delamination resistance for sensitive biologics

Japan Recent Developments:
✅ Nipro Corporation developed specialized molded vials with reduced alkaline extraction for heat-sensitive vaccine formulations
✅ Japan's MHLW implemented stricter glass quality standards for vaccine packaging following pandemic supply chain lessons
✅ Mitsubishi Chemical introduced lightweight molded vials with improved thermal shock resistance for tropical climate distribution

Buy Now and Enjoy a 30% Year-End Discount: https://www.datamintelligence.com/buy-now-page?report=glass-vaccine-vial-market

Competitive Landscape
The market features strong competition between global glass manufacturers, specialized pharmaceutical packaging companies, and material science innovators.

1. SCHOTT Pharma maintained market leadership with 28% global market share, expanding their molded vial portfolio and reporting 32% revenue growth in 2024-2025 through government vaccination contracts.
2. Corning Incorporated captured 25% market share in specialty glass, securing long-term agreements with vaccine manufacturers and achieving 35% growth through innovative Valor® Glass technology.
3. Gerresheimer AG dominated the pharmaceutical packaging segment with 22% market share, reporting 28% growth through comprehensive vial solutions.
4. Nipro Corporation led Asian market expansion with 18% market share, achieving 30% growth through regional manufacturing and distribution networks.
5. Stevanato Group expanded their integrated solutions with 15% market share, focusing on high-value applications with 26% revenue growth.

Speak to Our Analyst and Get Customization in the Report: https://www.datamintelligence.com/customize/glass-vaccine-vial-market?jd

Segmentation Analysis
By Product Type
• Molded Glass Vial segment is projected to be the dominant segment in the market during the forecast period with 58% revenue share in 2024, projected to grow at 11.5% CAGR, valued for superior chemical stability, excellent break resistance, cost-effectiveness in mass production, and widespread adoption in large-scale vaccination programs requiring reliable, high-volume packaging solutions.
• Tubular Glass Vial shows strong growth with 42% revenue share in 2024, expected to grow at 9.8% CAGR, preferred for premium vaccine formulations, specialized applications, and enhanced clarity requirements.

By Application
• Preventive Vaccine represents the largest segment with 72% revenue share in 2024, growing at 11.2% CAGR, driven by massive global immunization programs, routine childhood vaccinations, seasonal flu campaigns, government-funded public health initiatives, and expanding coverage of infectious disease prevention across both developed and emerging markets.
• Therapeutic Vaccine shows accelerated growth with 28% revenue share in 2024, expanding at 9.5% CAGR, valued for cancer immunotherapy, allergy treatments, and emerging applications in chronic disease management requiring specialized packaging solutions.

Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription?jd

Regional Analysis:
Asia Pacific holds the largest market share and emerges as the fastest-growing region with 46% revenue share in 2024, projected to expand at 12.8% CAGR through 2031, driven by massive population vaccination needs, expanding pharmaceutical manufacturing, growing government immunization programs, increasing healthcare expenditure, and strong production capabilities across China, India, Japan, and Southeast Asian countries.

North America and Europe demonstrate steady growth with advanced vaccine development and established immunization infrastructure, focusing on innovative packaging technologies and regulatory compliance.

Market Trends & Drivers
The Glass Vaccine Vial Market is experiencing robust growth driven by global health initiatives, pandemic preparedness, vaccine innovation, and packaging safety requirements. Key trends include the development of enhanced barrier properties, growth in ready-to-use formats, advancement in delamination resistance, expansion of sustainable manufacturing, and increasing focus on supply chain resilience. The vaccination expansion, regulatory standards, and technological innovation are significantly contributing to market growth.

Related Reports:
1. Pharmaceutical Glass Packaging Market - https://www.datamintelligence.com/research-report/pharmaceutical-glass-packaging-market?jd
2. Vaccine Delivery Devices Market - https://www.datamintelligence.com/research-report/vaccine-delivery-devices-market?jd
3. Cold Chain Packaging Market - https://www.datamintelligence.com/research-report/cold-chain-packaging-market?jd

Contact Us:
Sai Kiran
DataM Intelligence 4market Research LLP
Phone: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specialises in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.